TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Hepatitis A Vaccine Market, Global Outlook and Forecast 2022-2028

Hepatitis A Vaccine Market, Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 24 September 2022
  • Pages :71
  • Formats:
  • Report Code:SMR-7380171
OfferClick for best price

Best Price: $2600

Hepatitis A Vaccine Market Size, Share 2022


Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

This report contains market size and forecasts of Hepatitis A Vaccine in global, including the following market information:

Global Hepatitis A Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hepatitis A Vaccine Market Sales, 2017-2022, 2023-2028, (K Unit)

Global top five Hepatitis A Vaccine companies in 2021 (%)

The global Hepatitis A Vaccine market was valued at 726.3 million in 2021 and is projected to reach US$ 842.5 million by 2028, at a CAGR of 2.1% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Inactivated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hepatitis A Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis A Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Unit)

Global Hepatitis A Vaccine Market Segment Percentages, by Type, 2021 (%)

Inactivated Vaccine

Live Attenuated Vaccine

Global Hepatitis A Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Unit)

Global Hepatitis A Vaccine Market Segment Percentages, by Application, 2021 (%)

Government Institution

Private Sector

Other

Global Hepatitis A Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Unit)

Global Hepatitis A Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis A Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hepatitis A Vaccine revenues share in global market, 2021 (%)

Key companies Hepatitis A Vaccine sales in global market, 2017-2022 (Estimated), (K Unit)

Key companies Hepatitis A Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

KM Biologics

IMBCAMS

Convac

Report Attributes Report Details
Report Title Hepatitis A Vaccine Market, Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 71 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Hepatitis A Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis A Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis A Vaccine Overall Market Size
2.1 Global Hepatitis A Vaccine Market Size: 2021 VS 2028
2.2 Global Hepatitis A Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hepatitis A Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Hepatitis A Vaccine Players in Global Market
3.2 Top Global Hepatitis A Vaccine Companies Ranked by Revenue
3.3 Global Hepatitis A Vaccine Revenue by Companies
3.4 Global Hepatitis A Vaccine Sales by Companies
3.5 Global Hepatitis A Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hepatitis A Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hepatitis A Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis A Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis A Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis A Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis A Vaccine Market Size Markets, 2021 & 2028
4.1.2 Inactivated Vaccine
4.1.3 Live Attenuated Vaccine
4.2 By Type - Global Hepatitis A Vaccine Revenue & Forecasts
4.2.1 By Type - Global Hepatitis A Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis A Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis A Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Hepatitis A Vaccine Sales & Forecasts
4.3.1 By Type - Global Hepatitis A Vaccine Sales, 2017-2022
4.3.2 By Type - Global Hepatitis A Vaccine Sales, 2023-2028
4.3.3 By Type - Global Hepatitis A Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Hepatitis A Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Hepatitis A Vaccine Market Size, 2021 & 2028
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application - Global Hepatitis A Vaccine Revenue & Forecasts
5.2.1 By Application - Global Hepatitis A Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis A Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis A Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Hepatitis A Vaccine Sales & Forecasts
5.3.1 By Application - Global Hepatitis A Vaccine Sales, 2017-2022
5.3.2 By Application - Global Hepatitis A Vaccine Sales, 2023-2028
5.3.3 By Application - Global Hepatitis A Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Hepatitis A Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis A Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis A Vaccine Revenue & Forecasts
6.2.1 By Region - Global Hepatitis A Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis A Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis A Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Hepatitis A Vaccine Sales & Forecasts
6.3.1 By Region - Global Hepatitis A Vaccine Sales, 2017-2022
6.3.2 By Region - Global Hepatitis A Vaccine Sales, 2023-2028
6.3.3 By Region - Global Hepatitis A Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hepatitis A Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Hepatitis A Vaccine Sales, 2017-2028
6.4.3 US Hepatitis A Vaccine Market Size, 2017-2028
6.4.4 Canada Hepatitis A Vaccine Market Size, 2017-2028
6.4.5 Mexico Hepatitis A Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hepatitis A Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Hepatitis A Vaccine Sales, 2017-2028
6.5.3 Germany Hepatitis A Vaccine Market Size, 2017-2028
6.5.4 France Hepatitis A Vaccine Market Size, 2017-2028
6.5.5 U.K. Hepatitis A Vaccine Market Size, 2017-2028
6.5.6 Italy Hepatitis A Vaccine Market Size, 2017-2028
6.5.7 Russia Hepatitis A Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Hepatitis A Vaccine Market Size, 2017-2028
6.5.9 Benelux Hepatitis A Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hepatitis A Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Hepatitis A Vaccine Sales, 2017-2028
6.6.3 China Hepatitis A Vaccine Market Size, 2017-2028
6.6.4 Japan Hepatitis A Vaccine Market Size, 2017-2028
6.6.5 South Korea Hepatitis A Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Hepatitis A Vaccine Market Size, 2017-2028
6.6.7 India Hepatitis A Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hepatitis A Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Hepatitis A Vaccine Sales, 2017-2028
6.7.3 Brazil Hepatitis A Vaccine Market Size, 2017-2028
6.7.4 Argentina Hepatitis A Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis A Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hepatitis A Vaccine Sales, 2017-2028
6.8.3 Turkey Hepatitis A Vaccine Market Size, 2017-2028
6.8.4 Israel Hepatitis A Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Hepatitis A Vaccine Market Size, 2017-2028
6.8.6 UAE Hepatitis A Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A Vaccine Major Product Offerings
7.1.4 GSK Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GSK Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A Vaccine Major Product Offerings
7.2.4 Merck Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A Vaccine Major Product Offerings
7.3.4 Sanofi Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Sinovac
7.4.1 Sinovac Corporate Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A Vaccine Major Product Offerings
7.4.4 Sinovac Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sinovac Key News
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Corporate Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A Vaccine Major Product Offerings
7.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Zhejiang Pukang Key News
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Corporate Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Major Product Offerings
7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Changchun Institute of Biological Key News
7.7 KM Biologics
7.7.1 KM Biologics Corporate Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A Vaccine Major Product Offerings
7.7.4 KM Biologics Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 KM Biologics Key News
7.8 IMBCAMS
7.8.1 IMBCAMS Corporate Summary
7.8.2 IMBCAMS Business Overview
7.8.3 IMBCAMS Hepatitis A Vaccine Major Product Offerings
7.8.4 IMBCAMS Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 IMBCAMS Key News
7.9 Convac
7.9.1 Convac Corporate Summary
7.9.2 Convac Business Overview
7.9.3 Convac Hepatitis A Vaccine Major Product Offerings
7.9.4 Convac Hepatitis A Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Convac Key News
8 Global Hepatitis A Vaccine Production Capacity, Analysis
8.1 Global Hepatitis A Vaccine Production Capacity, 2017-2028
8.2 Hepatitis A Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis A Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis A Vaccine Supply Chain Analysis
10.1 Hepatitis A Vaccine Industry Value Chain
10.2 Hepatitis A Vaccine Upstream Market
10.3 Hepatitis A Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis A Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of Hepatitis A Vaccine in Global Market
Table 2. Top Hepatitis A Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hepatitis A Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hepatitis A Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Hepatitis A Vaccine Sales by Companies, (K Unit), 2017-2022
Table 6. Global Hepatitis A Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hepatitis A Vaccine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Hepatitis A Vaccine Product Type
Table 9. List of Global Tier 1 Hepatitis A Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis A Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis A Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hepatitis A Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hepatitis A Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hepatitis A Vaccine Sales (K Unit), 2017-2022
Table 15. By Type - Global Hepatitis A Vaccine Sales (K Unit), 2023-2028
Table 16. By Application ? Global Hepatitis A Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hepatitis A Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hepatitis A Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hepatitis A Vaccine Sales (K Unit), 2017-2022
Table 20. By Application - Global Hepatitis A Vaccine Sales (K Unit), 2023-2028
Table 21. By Region ? Global Hepatitis A Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hepatitis A Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hepatitis A Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hepatitis A Vaccine Sales (K Unit), 2017-2022
Table 25. By Region - Global Hepatitis A Vaccine Sales (K Unit), 2023-2028
Table 26. By Country - North America Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hepatitis A Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hepatitis A Vaccine Sales, (K Unit), 2017-2022
Table 29. By Country - North America Hepatitis A Vaccine Sales, (K Unit), 2023-2028
Table 30. By Country - Europe Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hepatitis A Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hepatitis A Vaccine Sales, (K Unit), 2017-2022
Table 33. By Country - Europe Hepatitis A Vaccine Sales, (K Unit), 2023-2028
Table 34. By Region - Asia Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hepatitis A Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hepatitis A Vaccine Sales, (K Unit), 2017-2022
Table 37. By Region - Asia Hepatitis A Vaccine Sales, (K Unit), 2023-2028
Table 38. By Country - South America Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hepatitis A Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hepatitis A Vaccine Sales, (K Unit), 2017-2022
Table 41. By Country - South America Hepatitis A Vaccine Sales, (K Unit), 2023-2028
Table 42. By Country - Middle East & Africa Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hepatitis A Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hepatitis A Vaccine Sales, (K Unit), 2017-2022
Table 45. By Country - Middle East & Africa Hepatitis A Vaccine Sales, (K Unit), 2023-2028
Table 46. GSK Corporate Summary
Table 47. GSK Hepatitis A Vaccine Product Offerings
Table 48. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Hepatitis A Vaccine Product Offerings
Table 51. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Hepatitis A Vaccine Product Offerings
Table 54. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sinovac Corporate Summary
Table 56. Sinovac Hepatitis A Vaccine Product Offerings
Table 57. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Zhejiang Pukang Corporate Summary
Table 59. Zhejiang Pukang Hepatitis A Vaccine Product Offerings
Table 60. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Changchun Institute of Biological Corporate Summary
Table 62. Changchun Institute of Biological Hepatitis A Vaccine Product Offerings
Table 63. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. KM Biologics Corporate Summary
Table 65. KM Biologics Hepatitis A Vaccine Product Offerings
Table 66. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. IMBCAMS Corporate Summary
Table 68. IMBCAMS Hepatitis A Vaccine Product Offerings
Table 69. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Convac Corporate Summary
Table 71. Convac Hepatitis A Vaccine Product Offerings
Table 72. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Hepatitis A Vaccine Production Capacity (K Unit) of Key Manufacturers in Global Market, 2020-2022 (K Unit)
Table 74. Global Hepatitis A Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Hepatitis A Vaccine Production by Region, 2017-2022 (K Unit)
Table 76. Global Hepatitis A Vaccine Production by Region, 2023-2028 (K Unit)
Table 77. Hepatitis A Vaccine Market Opportunities & Trends in Global Market
Table 78. Hepatitis A Vaccine Market Drivers in Global Market
Table 79. Hepatitis A Vaccine Market Restraints in Global Market
Table 80. Hepatitis A Vaccine Raw Materials
Table 81. Hepatitis A Vaccine Raw Materials Suppliers in Global Market
Table 82. Typical Hepatitis A Vaccine Downstream
Table 83. Hepatitis A Vaccine Downstream Clients in Global Market
Table 84. Hepatitis A Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis A Vaccine Segment by Type
Figure 2. Hepatitis A Vaccine Segment by Application
Figure 3. Global Hepatitis A Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis A Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis A Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Hepatitis A Vaccine Sales in Global Market: 2017-2028 (K Unit)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis A Vaccine Revenue in 2021
Figure 9. By Type - Global Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hepatitis A Vaccine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hepatitis A Vaccine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 19. US Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 33. China Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hepatitis A Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hepatitis A Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hepatitis A Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hepatitis A Vaccine Production Capacity (K Unit), 2017-2028
Figure 49. The Percentage of Production Hepatitis A Vaccine by Region, 2021 VS 2028
Figure 50. Hepatitis A Vaccine Industry Value Chain
Figure 51. Marketing Channels

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount